Astraveus builds high tech equipment supporting end-to-end development and manufactures of cell and gene therapies. Here are details of Astraveus‘ latest funding round :
🚀 Launch
2016
🏭 Industry
Biotechnology
🧠Management
DR JÉRÉMIE LAURENT (CEO), VINCENT THISSE (Head of Lakhesys), DR GIULIA GHINATTI (Head of Applications), DR XUE HOU (Head of Microtechnologies), DR CAROLINE RICHARD (VP Strategy & RA), ANDRÉE BLEHER (Head of Administration and Finance)
💸 Funding & Investors
| INVESTMENT (October 2023) | €10.4 million |
| INVESTORS (October 2023) | This non-dilutive funding closely follows the #FrenchTech2030 accreditation led by the Secrétariat Général Pour l’Investissement (“SGPI)”, building upon the ongoing support received from the French and European innovation ecosystem, and the recent closure of an oversubscribed €16.5M seed financing round. |
🎯 Funding purpose
Advance the development of its Lakhesys ™ platform.
🌐 Country HQ
France (Paris)